Dr. Lal PathLabs (NSE:LALPATHLAB) Short Interest

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:LALPATHLAB Dr. Lal PathLabs Ltd NSE:LALPATHLAB
93 GF Score
Price ₹1,949.90
GF Value ₹1,735.83
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Dr. Lal PathLabs Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

NSE:LALPATHLAB vs TMO, DHR, IDXX: Short Interest Comparison

For the Diagnostics & Research subindustry, Dr. Lal PathLabs's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Dr. Lal PathLabs Short Interest vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Dr. Lal PathLabs's Short Interest distribution charts can be found below:

* The bar in red indicates where Dr. Lal PathLabs's Short Interest falls into.


NSE:LALPATHLAB
93GF Score
Dr. Lal PathLabs Ltd NSE:LALPATHLAB
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dr. Lal PathLabs (NSE:LALPATHLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Dr. Lal PathLabs stock appears to be overvalued. The current stock price of ₹1,949.90 is trading 12.3% above its estimated GF Value™ of ₹1,735.83. GuruFocus considers Dr. Lal PathLabs to be Modestly Overvalued.

Key valuation signals for NSE:LALPATHLAB:

  • Short Interest:
  • GF Value™: ₹1,735.83 vs. price of ₹1,949.90 (12.3% above fair value)
  • GF Score™: 93/100 with 5 warning signs

No single metric tells the full story. See the NSE:LALPATHLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dr. Lal PathLabs Business Description

Other Exchanges 539524:India
Address 12th Floor, Tower B, SAS Tower, Sector 38, Medicity, Gurugram, HR, IND, 122 001
Dr. Lal PathLabs Ltd is a pathology lab based in India. It is involved in providing diagnostic services and other healthcare tests in the areas of pathology and radiology. The company operates laboratories for carrying out pathological diagnostic services in various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations. Its diagnostic services assist in preventing, monitoring, and treating diseases and improving health conditions. The company has business operations in India and other countries, of which maximum revenue is generated within India.
93GF Score

Get the complete analysis for NSE:LALPATHLAB

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,949.90
Price
₹1,735.83
GF Value